Cargando…
Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker
INTRODUCTION: RALA is a member of the small GTPase Ras superfamily and has been shown to play a role in promoting cell proliferation and migration in most tumors, and increase the resistance of anticancer drugs such as imatinib and cisplatin. Although many literatures have studied the cancer-promoti...
Autores principales: | Jin, Haoer, Qin, Sha, He, Jiang, Xiao, Juxiong, Li, Qingling, Mao, Yitao, Zhao, Luqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713825/ https://www.ncbi.nlm.nih.gov/pubmed/36466919 http://dx.doi.org/10.3389/fimmu.2022.1046044 |
Ejemplares similares
-
New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials
por: Jin, Haoer, et al.
Publicado: (2022) -
The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma
por: Qin, Sha, et al.
Publicado: (2022) -
The comprehensive expression and functional analysis of m6A modification “readers” in hepatocellular carcinoma
por: Qin, Sha, et al.
Publicado: (2022) -
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
por: Qin, Sha, et al.
Publicado: (2021) -
Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
por: Fan, Gentao, et al.
Publicado: (2023)